|
TSR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.58690000001882E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.31209999999038E-05 |
| Normal-vs-Stage2 |
1.111820E-02 |
| Normal-vs-Stage3 |
1.6075999999976E-05 |
| Normal-vs-Stage4 |
5.61620000000262E-05 |
| Stage1-vs-Stage2 |
3.809800E-01 |
| Stage1-vs-Stage3 |
3.521400E-01 |
| Stage1-vs-Stage4 |
4.444600E-01 |
| Stage2-vs-Stage3 |
1.667560E-01 |
| Stage2-vs-Stage4 |
1.990810E-01 |
| Stage3-vs-Stage4 |
9.647000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.73559999999884E-05 |
| Normal-vs-AfricanAmerican |
3.015400E-03 |
| Normal-vs-Asian |
1.198170E-03 |
| Caucasian-vs-AfricanAmerican |
9.283800E-01 |
| Caucasian-vs-Asian |
9.080000E-01 |
| AfricanAmerican-vs-Asian |
8.687400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65829999998479E-06 |
| Normal-vs-Female |
3.67290000000686E-05 |
| Male-vs-Female |
1.890830E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.643300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.72030000000767E-06 |
| Normal-vs-Age(61-80Yrs) |
2.026700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.157160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.432600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.345000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.876400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.302200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.162000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.266400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.186800E-01 |
| Classical-VS-Follicular |
1.263580E-03 |
| Classical-VS-Other |
7.993800E-02 |
| Classical-VS-Normal |
4.761700E-04 |
| Tall-VS-Follicular |
4.529200E-01 |
| Tall-VS-Other |
3.215200E-01 |
| Tall-VS-Normal |
9.212700E-04 |
| Follicular-VS-Other |
5.560200E-01 |
| Follicular-VS-Normal |
5.41859999980687E-07 |
| Other-VS-Normal |
2.537300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.84530000000039E-06 |
| Normal-vs-N1 |
4.29480000000426E-05 |
| N0-vs-N1 |
3.367600E-01 |
|
|
